# Lisdexamfetamine Dimesylate

NDC: 0527-4665
Generic name: Lisdexamfetamine Dimesylate
Labeler / Manufacturer: Lannett Company, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230825

FDA application: ANDA215802

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0527-4665"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0527-4665
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2cedb4c2-1e40-4bc4-b9f4-127150c4afbd